Cargando…
Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmonary disease
BACKGROUND: Oral corticosteroids were used to control stable chronic obstructive pulmonary disease (COPD) decades ago. However, recent guidelines do not recommend long-term oral corticosteroids (LTOC) use for stable COPD patients, partly because it causes side-effects such as respiratory muscle dete...
Autores principales: | Horita, Nobuyuki, Miyazawa, Naoki, Morita, Satoshi, Kojima, Ryota, Inoue, Miyo, Ishigatsubo, Yoshiaki, Kaneko, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976535/ https://www.ncbi.nlm.nih.gov/pubmed/24708443 http://dx.doi.org/10.1186/1465-9921-15-37 |
Ejemplares similares
-
Statins reduce all-cause mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis of observational studies
por: Horita, Nobuyuki, et al.
Publicado: (2014) -
Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: a propensity score matching study
por: Horita, Nobuyuki, et al.
Publicado: (2013) -
Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study
por: Inoue, Satoshi, et al.
Publicado: (2011) -
Synchronous lung and gastric cancers successfully treated with carboplatin and pemetrexed: a case report
por: Sato, Takashi, et al.
Publicado: (2012) -
The triple therapy for chronic obstructive pulmonary disease increases the risk of pneumonias compared to the dual-bronchodilator therapy
por: Watanabe, Keisuke, et al.
Publicado: (2021)